In this episode of the Merge Medical Deep Dive Podcast, Drs. Jeff Brown and Jeff Cole speak with Rob Bohacs, Founder and CEO of Researchify Health.

Researchify Health is a revenue-stage AI company transforming clinical trial recruitment and patient engagement. Generating $900K in SaaS revenue in 2025, with a projected ARR of $1.3M by the end of next year, the company leverages AI-driven, SMS-based communication to streamline patient pre-screening, scheduling, and ongoing trial updates.

Researchify Health’s platform accelerates clinical trial participation, simplifies scheduling, and drives higher engagement through consistent follow-ups and AI study matching. This streamlined process guides patients seamlessly through their clinical trial journey, helping to bring drugs to market more rapidly.

Founded by seasoned clinical trial entrepreneurs with two prior exits, Researchify Health addresses key pain points in clinical trial enrollment. With a track record of innovation, the company is poised to become a leading AI platform in clinical trial engagement.

A visual overview of their solution can be found here: https://youtu.be/G3FQI-cic0E

Investment and Strategic Partner Opportunities:

Researchify Health has been founder-funded and is now seeking its first external capital raise of $800K through a convertible note, structured with a 5% annual interest rate, a 10% discount, and a $6.5M cap.

*****

Would this bring value to you, your family or your medical practice? Investable merits of this company? Let’s discuss in the forum.

If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion.

Sign up today!

https://mergemedical.community.forum/

*****

DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

Take the demo for a spin. It’s set up as a dentistry practice, so you can role-play scheduling an appointment. Challenge the AI by asking tough questions or even making inappropriate statements—things that would test your best staff members. You’ll be amazed by its professionalism, natural voice inflections, and overall performance.

Demo Link (6 min full demo)

or Demo call line: 928-492-5907

And there’s more to it than just that.

In this episode of the Merge Medical Deep Dive Podcast, Drs. Jeff Brown and Jeff Cole speak with Rahul Sharma, co-founder and CEO of Neurality Health.

Neurality Health AI streamlines the administrative and operational tasks of both the front and back office using human-like voice and text. The AI handles inbound calls, schedules appointments, educates patients, and enhances engagement through recall and reactivation programs. It also verifies insurance benefits, manages payer communications, and has the potential to take on other revenue cycle management (RCM) responsibilities.

Neurality Health’s onboarding process also includes several proprietary and AI-enhanced processes allowing them to add pilot practices and paying customers quickly and with ease. Their sales are reaching an inflection point where some might even say they are “exploding” to the upside. The company is rapidly expanding from its initial focus on dentistry into multiple medical subspecialties.

Founded by seasoned health tech entrepreneurs and AI experts, Neurality Health is addressing key pain points faced by clinicians. With a track record of success and a focus on continued innovation, Neurality Health is poised to become the AI operating system of the future for healthcare.

Investment and strategic partner opportunities:

Neurality Health quickly closed a $350K pre-seed round largely funded by subject matter experts and customers within their initial target market of dentistry. They have opened an add-on pre-seed round also structured as a Y-Combinator SAFE note at a compelling valuation of $5M. Strategic partners and investors have been identified within several medical specialties such as ENT and orthopedic surgery. This offering is capped at $500K and may be filled by the time of this publication.

*****

Would this bring value to you or your medical practice? Investable merits of this company? Let’s discuss in the forum.

If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today!

https://mergemedical.community.forum/

*****

DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

Here’s the thing about patient care – the caring never stops. Patients and their healthcare providers have questions, and answers just can’t wait. To find these answers, healthcare professionals “run cases by each other”. These casual “curbside” consultations are vital to improve access to specialty expertise.

Join Drs Jeff Brown and Jeff Cole in the “Deep Dive” version of the Merge Medical podcast as they interview Dr. Richard Popwell, CEO and Founder of DocSide.

There was a time when a much higher density of physicians would cross paths in the physician’s lounge, surgery lounge or cafeteria of the typical hospital. Curbside consults have always been part of the culture of medicine, but times have changed. A large percentage of physicians and healthcare providers are now working in outpatient clinics and/or outpatient surgery centers. Sub-specialists simply don’t cross paths the way they they did 20 or 30 years ago.

Curbsides aren’t always so easy. . . From finding the right expert, playing phone tag, interrupting each other’s work and family life. . . What’s meant to save time and effort does anything but…

So, what if there was a way to simplify collaboration between healthcare professionals and facilitate safe, high quality, and equitable care for any patient, anywhere, anytime?

Welcome to the DocSide! DocSide is an intuitive mobile and web-based solution that creates more equitable access, reduces costs, and optimizes care by empowering healthcare professionals with seamless curbside collaboration, shared documentation, and revenue generation. DocSide is more than just another healthcare app. It’s a place . . .

• Where a GP in rural America can consult with specialists in a large, urban medical center.
• Where patients don’t always have to drive to another appointment to get the care they need.
• Where curbsides create access and improve care with just the right amount of simple documentation.
• Where care is customized and outcomes optimized because over 3 million healthcare professionals can better serve 300 million potential patients.
• Where your time and expertise are rewarded both personally and financially.
• And, instead of burning out . . . there’s helping out.

Welcome to the DocSide!

Where curbsides are more connected.

To learn more about DocSide, including potential investment opportunities, visit www.docsideapp.com

email connect@docsideapp.com

or call 406-224-5297.

*****

Would this bring value to you, your family or your medical practice? Investable merits of this company? Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion.

Sign up today! https://mergemedical.community.forum/

*****

DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

Have founder Kenneth A. Levey, MD, MPH and the team at Mother Goose Health developed a multimodal approach that significantly reduces preterm birth?

Join Drs Jeff Brown and Jeff Cole in the “Deep Dive” version of the Merge Medical podcast as they interview Shelle’ Jones and Dr. Ken Levey, CEO and Founder of Mother Goose Health.

Mother Goose Health is a maternity care management company that better supports patients and providers in achieving optimal maternal and infant health outcomes by unifying the maternity care ecosystem within a single platform. Through seamless integrations, the Mother Goose Health platform improves care coordination while also reducing provider workload through care management and support. Targeted, proprietary risk-detection algorithms identify rising risk which allows proactive care.

Kenneth A. Levey, MD, MPH is a board-certified obstetrician-gynecologist, and the founder of New York City’s largest independently owned Women’s Health practice. Dr. Levey has launched several healthcare technology companies aimed at better supporting the patient-provider dyad, including his latest Mother Goose Health.

Mother Goose Health’s provider-patient focus has proven ability to reduce adverse pregnancy events, including reducing preterm birth by more than 50% in a 2023 case-control study.

*****

Would this bring value to you, your family or your medical practice? Investable merits of this company?

Let’s discuss in the forum. If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion.

Sign up today! https://mergemedical.community.forum/

*****

DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

“Deep Dive″ or uncut version of our video podcast. Drs Jeff Brown and Jeff Cole interview Dr. David Kay (CMO) and Gabe Szabo (CEO) or Surgical Targeted Solutions, Inc. Both gentlemen have had enormous success building and operating medical companies. For Dr. Kay, Orthohelix was the first company that he helped form, build and exit.

As technology continues to rapidly advance in healthcare, there are times when solutions don’t bring adequate value when compared to the steep learning curves and restrained budgets. As just one example, rather than trying to find ways to use robotic assistance in surgery for an increasing number of things, some of the most impactful potential gains relate to improving process and understanding “why we do what we do”.

One example of this is in the surgical treatment of hip fractures. Given the changing population demographics, hip fractures are expected to rise dramatically over the next 10 years, all while the surgeon pool is shrinking. As new surgeons come on board to deal with this exploding volume, there risks a wide range in skill and experience level that make OR staffing very difficult. It’s hard to allocate resources when the same operation can range from 30 minutes to 120 minutes.

Has the team at Surgical Targeted Solutions, Inc. found a potential solution for this problem and created a cost-effective, simple tool that provides reliability and reproducibility for improved hip fracture outcomes?

The first step in the surgical treatment is placement of a guidewire within a center-head position. This solution changes an unguided first step to one that is computer-assisted and guided so that optimal positioning of the implant can be achieved THE FIRST TIME…EVERY TIME.

Compared with robot-assisted procedures, this solution offers affordability, simplicity, adaptability and an easy or quick learning curve. This system can also be used in the training of residents to bring balance between skill and experience levels.

The benefits to cost and outcome are significant and include decreased OR time, more predictable procedure length, fewer complications, less radiation and reduction in implant waste or explants.

During the FDA process and early commercialization, Surgical Targeted Solution, Inc will be highly focused on the hip fracture market. With that said there are numerous additional adaptations covered under their patent and where solutions and business will be developed.

*****

Would this bring value to you, your family or your medical practice? Investable merits of this company? Let’s discuss in the forum.

If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today!

https://mergemedical.community.forum/

*****

DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

Stated as a matter of fact, cybersecurity is a big f*^&%ing deal.

Join us in a Deep Dive version of the Merge Medical podcast as Dr. Jeff Brown and Dr. Jeff Cole interview Dr. Jose Bolanos. Dr. Bolanos is founder and CEO of Nimbus-T Global and offers a compelling opportunity for enterprise and individuals alike to protect themselves in a world full of bad actors.

Cybersecurity threats can hit home in so many ways. Unfortunately, the medical profession and healthcare industry seem to be like fish in a barrel. Constant threats, frequent losses...and few, if any, wins.

In addition to high profile ransomware attacks such as Change Healthcare and Ascension, there are countless direct attacks on medical practices. One of these attacks can easily bankrupt a successful, long standing medical practice.

With billion-dollar market cap companies trying to create meaningful solutions and put a notch in the win column, is it possible that a physician holds the keys to one of the most revolutionary solutions in existence?

Moving well beyond two-factor authentication (2FA) and multi-factorial authentication (MFA), Nimbus-T Global / Nimbus-Key ID provides the most advanced cybersecurity protection at login to enterprise systems. The Nimbus-Key ID mobile app registers each user with KYC/AI/Biometric verification. The user logs into the mobile app with True User Verification and the system bypasses passwords with dynamically encrypted ID in a QRcode (DE-MFA). This system protects the enterprise login process and the user’s true access.

Also, having experience with poor cooperation across the myriad of software systems required for the day-to-day activities of both office-based and hospital-based physicians, much thought has gone into the time efficiency of the hardware-agnostic process.

If you have escaped direct cybersecurity threat or loss up to this point, some experts would say that it’s only a matter of time.

Tune in to the latest Merge Medical podcast to learn more.

*****

Would this bring value to you, your family or your medical practice? Investable merits of this company? Let’s discuss in the forum.

If you are a physician or healthcare professional with an NPI number, you can register for our private forum to join the discussion. Sign up today!

https://mergemedical.community.forum/

*****

DISCLAIMER: Merge Medical and the podcast hosts are providing this content for informational and entertainment purposes only and are not broker dealers or registered investment advisors. We are not providing investment or legal advice. We will bring awareness to interesting projects and companies and then leave further discussion of the clinical and/or investable merits of these companies up to free discussion within the forum. Additionally, podcast participants (including the hosts) and Merge Medical forum members may or may not have a financial interest within the companies being interviewed or featured.

Welcome to the Merge Medical Podcast, where today’s healthcare innovators and leaders come together to shape tomorrow’s healthcare landscape. In our latest episode, we’re honored to host Dr. Robert Pearl, the former CEO of Kaiser Permanente, a prolific author and a visionary in the fields of AI and healthcare.

Dr. Robert Pearl was the CEO of The Permanente Medical Group (Kaiser Permanente) from 1999-2017. In this role he led 12,000 physicians, 42,000 staff and was responsible for the nationally recognized medical care of over 5 million Kaiser Permanente members on the west and east coasts.

His newest book, “ChatGPT, MD: How AI-Empowered Patients & Doctors Can Take Back Control of American Medicine” debuted as #1 on Amazon’s “New Best Seller” list. All profits from the book go to Doctors Without Borders. He is also the author of “Mistreated: Why We think We’re Getting Good Healthcare—And Why We’re Usually Wrong,” a Washington Post bestseller and “Uncaring: How the Culture of Medicine Kills Doctors and Patients,” published May 2021.

Pearl, named one of Modern Healthcare’s 50 most influential physician leaders, serves as a clinical professor of plastic surgery at Stanford University School of Medicine and is on the faculty of the Stanford Graduate School of Business.

He hosts the popular podcasts Fixing Healthcare and Medicine: The Truth, publishes a newsletter called Monthly Musings on American Healthcare, and is a regular contributor to Forbes.

Dr. Pearl received his medical degree from the Yale University School of Medicine and completed his residency at Stanford University.

Connect with Dr. Robert Pearl on Twitter @RobertPearlMD, LinkedIn and at his website robertpearlmd.com.

Welcome to the Merge Medical Podcast, where today's healthcare innovators and leaders come together to shape tomorrow's healthcare landscape. In our latest episode, we're honored to host Dr. Harvey Castro, a visionary ER physician, AI healthcare futurist, and prolific author in the field of AI and healthcare. Dr. Castro delves into how artificial intelligence is revolutionizing patient care and physician practices, sharing his journey in developing AI technologies aimed at improving outcomes and building a sustainable future for healthcare professionals. Discover the potential of AI to transform healthcare delivery, enhance patient experiences, and unlock new avenues for private practice growth and wealth creation.

This is a must-listen for anyone passionate about the intersection of healthcare and technology, seeking practical insights and inspiration to navigate the challenges and opportunities ahead. Join us as Dr. Harvey Castro leads the way in leveraging AI for a healthier tomorrow.

Merge Medical Website: https://mergemedical.org

LinkedIn Newsletter: https://www.linkedin.com/build-relation/newsletter-follow?entityUrn=7080491988705234946